Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy.

Delisle MB, Murrell JR, Richardson R, Trofatter JA, Rascol O, Soulages X, Mohr M, Calvas P, Ghetti B.

Acta Neuropathol. 1999 Jul;98(1):62-77.

PMID:
10412802
2.

[Neurodegenerative disease associated with a mutation of codon 279 (N279K) in exon 10 of Tau protein].

Delisle MB, Uro-Coste E, Murrell JR, Rascol O, Ghetti B.

Bull Acad Natl Med. 2000;184(4):799-809; discussion 809-11. Review. French.

PMID:
10989564
3.

Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).

Spillantini MG, Van Swieten JC, Goedert M.

Neurogenetics. 2000 Mar;2(4):193-205. Review.

PMID:
10983715
4.
5.

Molecular genetics of chromosome 17 tauopathies.

Hutton M.

Ann N Y Acad Sci. 2000;920:63-73. Review.

PMID:
11193178
6.

[Japanese contribution to the understanding of frontotemporal dementia and parkinsonism linked to chromosome 17(FTDP-17)].

Tsuboi Y, Wszolek ZK, Mizuno Y, Kobayashi T, Yasuda M, Yamada T.

No To Shinkei. 2003 Feb;55(2):107-19. Review. Japanese.

PMID:
12684990
7.

Neuropathology of familial tauopathy.

Tsuboi Y.

Neuropathology. 2006 Oct;26(5):471-4. Review.

PMID:
17080727
8.

Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies.

Spillantini MG, Bird TD, Ghetti B.

Brain Pathol. 1998 Apr;8(2):387-402. Review.

PMID:
9546295
9.

Tau gene mutations and neurodegeneration.

Goedert M, Spillantini MG.

Biochem Soc Symp. 2001;(67):59-71. Review.

PMID:
11447840
10.

[Frontotemporal dementia: tau mutations, deposition, and molecular mechanisms of neuronal cell death].

Hasegawa M.

Rinsho Shinkeigaku. 2004 Nov;44(11):879-81. Review. Japanese.

PMID:
15651320
12.

Phenotypic correlations in FTDP-17.

Reed LA, Wszolek ZK, Hutton M.

Neurobiol Aging. 2001 Jan-Feb;22(1):89-107. Review.

PMID:
11164280
13.

Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.

Zhou J, Yu Q, Zou T.

BMC Neurosci. 2008 Dec 3;9 Suppl 2:S10. doi: 10.1186/1471-2202-9-S2-S10. Review.

14.

[Molecular analysis of tau deposited in the FTDP-17 brain].

Morishima-Kawashima M.

Rinsho Shinkeigaku. 2001 Dec;41(12):1107-10. Review. Japanese.

PMID:
12235810
15.

Recent advances in the understanding of tau protein and movement disorders.

Arvanitakis Z, Wszolek ZK.

Curr Opin Neurol. 2001 Aug;14(4):491-7. Review.

PMID:
11470966
16.

Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease.

Borroni B, Agosti C, Magnani E, Di Luca M, Padovani A.

Curr Med Chem. 2011;18(17):2655-60. Review.

PMID:
21568901
17.

Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy.

Kertesz A, Munoz D.

Dement Geriatr Cogn Disord. 2004;17(4):282-6. Review.

PMID:
15178937
18.

[Progressive supranuclear palsy; an unusual form of parkinsonism].

Donker Kaat L, Boon AJ, Heutink P, van Swieten JC.

Ned Tijdschr Geneeskd. 2004 Mar 13;148(11):519-23. Review. Dutch.

PMID:
15054950
19.

Neurodegenerative tauopathies.

Lee VM, Goedert M, Trojanowski JQ.

Annu Rev Neurosci. 2001;24:1121-59. Review.

PMID:
11520930
20.

Neurodegenerative disorders with extensive tau pathology: a comparative study and review.

Feany MB, Dickson DW.

Ann Neurol. 1996 Aug;40(2):139-48. Review.

PMID:
8773594

Supplemental Content

Support Center